Upcoming Webinar: Advancing Patient and Caregiver-Centered Approaches in Neurodegenerative Clinical Trials
Neurodegenerative clinical trials present unique challenges that extend beyond scientific and operational complexity. Disease progression, caregiver responsibilities, travel burden, complex...
Inside AD/PD 2026: Emerging Breakthroughs in Alzheimer’s and Parkinson’s
Authors: Carmen Gasca-Salas, MD, MSc, PhD, Medical Director, Medpace Recently, the Medpace neuroscience team attended the AD/PD (Alzheimer’s & Parkinson’s Disease)...
Medpace Expands Medical Leadership Team with Expert in Parkinson’s Disease
Neuroscience and Cognition and brings extensive expertise in the design and execution of Parkinson’s disease research. Additionally, she has over...
Top 3 Key Takeaways from ENCALS 2025
Medpace Medical and Clinical Operations Experts Share Key Insights from the ENCALS Meeting
Exciting CNS Breakthroughs: Where the Promise Lies
In a recent PharmaVoice article "Brain Wave: Breakthroughs Bring New Hope to CNS", Dr. Rick Scheyer, Vice-President, Medical Affairs at Medpace, provides comment on the state of…